• Explore /
  • Poster
  • / Estrogen levels in premenopausal (prem) patients (pts) with hormone-receptor positive (HR+) early breast cancer (BC) receiving adjuvant  triptorelin (Trip) plus exemestane (E) or tamoxifen (T) in the SOFT trial: SOFT-EST substudy.

Estrogen levels in premenopausal (prem) patients (pts) with hormone-receptor positive (HR+) early breast cancer (BC) receiving adjuvant  triptorelin (Trip) plus exemestane (E) or tamoxifen (T) in the SOFT trial: SOFT-EST substudy.

Abstract Poster

Authors

Meritxell Bellet

Meritxell Bellet

Vall d'Hebron University Hospital, Barcelona, Spain

Meritxell Bellet , Kathryn P. Gray , Prudence A. Francis , Istvan Lang , Eva Ciruelos , Ana Lluch , Miguel Angel Climent , Gustavo Catalan , Roser Ferrer Costa , Roberto Catalan , Agnita Rajasekaran , Josefa Morales , Josep Vazquez , Gini F. Fleming , Karen N. Price , Meredith M. Regan

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2014 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Breast Cancer - HER2/ER

Track

Breast Cancer

Sub Track

ER+

Clinical Trial Registration Number

NCT00066703/NCT00066690

Citation

J Clin Oncol 32:5s, 2014 (suppl; abstr 585)

DOI

10.1200/jco.2014.32.15_suppl.585

Abstract #

585

Poster Bd #

49

Abstract Disclosures

Similar Posters

First Author: Juerg Bernhard

First Author: D. W. Cescon

First Author: F. Perrone

First Author: Megan Elizabeth Tesch